Ropivacaine and Midazolam by Intraarticular vs Epidural Administration in Arthroscopic ACL
Anterior Cruciate Ligament Injuries, Anesthesia Injection Site, Knee Injuries
About this trial
This is an interventional treatment trial for Anterior Cruciate Ligament Injuries focused on measuring Knee infiltration, Anterior Cruciate Ligament, Hamstring, Ropivacaine, Midazolam
Eligibility Criteria
Inclusion Criteria:
- Age over 18 years and younger than 50 years
- Arthroscopic single bundle anterior cruciate ligament anatomic reconstruction with hamstring tendon autograft
- Unilateral procedure
- With or without meniscal tear
- Desire to participate voluntarily in the study and signature of informed consent
- Pre-operative assessment with result between (American Society of Anesthesiologist) ASA I or ASA II performed and annexed in the clinical file either by the Department of Internal Medicine, Cardiology or Anesthesiology.
Exclusion Criteria:
- Another ligament surgery (posterior cruciate ligament, medial collateral ligament, posterolateral corner reconstruction)
- ACL reconstruction with allograft
- Bone to bone or quadriceps autograft
- ACL reconstruction with double bundle technique
- Patients with previous knee surgeries
- Open ACL reconstruction
- Corrective knee osteotomy or articular cartilage repair surgery, meniscal transplant, lateral extraarticular tenodesis
- Pregnant or lactating patients
- Patients under 18 years old
- Patients consuming oral contraceptives
- Patients who present any contraindication for neuraxial blockade (e.g., coagulation defects, infection at the puncture site, pre-existing neurological deficits in the lower extremities, Anticoagulant or antiplatelet therapy that has not been suspended 48 hours before the surgery, systemic infection, fever above 38.5º)
- Preoperative assessment with ASA III-IV
- Hypersensitivity to the drugs used in the study
- Patients with intellectual impairments or psychiatric conditions that limited adequate communication
- Patients with a diagnosis of fibromyalgia, polymyalgia rheumatica, complex painful syndromes or sciatic neuropathy
Sites / Locations
- Universidad Autonoma de Nuevo Leon
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ropivacaine and midazolam epidural administration
Ropivacaine and midazolam intraarticular administration
An elastomeric pump was prepared for epidural infusion. This was prepared with 150 mg (20 ml) of 0.75% ropivacaine plus midazolam at 50 mcg / kg / 12 hrs. The solution was made up to 125 ml with physiological solution. And 20 ml of physiological solution, was intraarticular administered as placebo.
Ropivacaine 0.75% at 1.5 mg / kg was used with midazolam at 50 mcg / kg, to complete 20 ml of solution and was administrated on the knee articulation after tourniquet release. And an elastomeric pump was prepared for epidural infusion, with 150 ml of physiological solution as placebo.